UCAR-NK cells (universal CD19-targeted)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for UCAR-NK cells (universal CD19-targeted), covering 2022-12-21 to 2022-12-21. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Universal CD19-Targeted UCAR-NK Cells Combined With HSCT for B Cell Hematologic Malignancies [Phase 1, Phase 2]